Related Experiment Videos
Inhaled nitric oxide in acute respiratory failure in adults
J D Young1, W J Brampton, J D Knighton
1Intensive Care Unit, John Radcliffe Hospital, Headley Way, Oxford.
British Journal of Anaesthesia
|October 1, 1994
Summary
Inhaled nitric oxide significantly improved oxygenation in severe acute respiratory failure patients. While it reduced pulmonary artery pressure, the primary benefit was enhanced arterial oxygen tension, particularly in patients with high pulmonary vascular resistance.
Area of Science:
- Pulmonary Medicine
- Critical Care Medicine
- Pharmacology
Background:
- Severe acute respiratory failure presents significant challenges in managing pulmonary haemodynamics and oxygenation.
- Inhaled nitric oxide (iNO) has emerged as a potential therapeutic agent for respiratory distress.
Purpose of the Study:
- To evaluate the acute effects of varying doses of inhaled nitric oxide on pulmonary haemodynamics and arterial oxygenation in patients with severe acute respiratory failure.
- To determine the relationship between pre-treatment pulmonary vascular resistance and the response to iNO.
Main Methods:
- A prospective study involving 14 mechanically ventilated patients with severe acute respiratory failure (mean pulmonary artery pressure > 30 mm Hg).
- Patients received inhaled nitric oxide at doses of 8, 32, and 128 volumes per million (vpm) for 10 minutes.
- Pulmonary haemodynamics and arterial blood gas tensions were measured before and after iNO inhalation.
Main Results:
- Inhaled nitric oxide significantly decreased mean pulmonary artery pressure and pulmonary vascular resistance at doses of 32 and 128 vpm (P < 0.05).
- Arterial oxygen tension (PaO2) significantly increased across all tested iNO doses (P < 0.05).
- The improvement in oxygenation correlated directly with baseline pulmonary vascular resistance.
Conclusions:
- Inhaled nitric oxide effectively improves arterial oxygenation in patients with severe acute respiratory failure.
- The primary benefit of iNO in this setting appears to be enhanced oxygenation, with pulmonary artery pressure reduction being a secondary effect.
- The dose-dependent response and the correlation with baseline pulmonary vascular resistance suggest a targeted application for iNO in managing acute respiratory failure.